Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-09

AUTHORS

Seo-Yeon Ahn, Sung-Hoon Jung, Young Don Joo, Won Sik Lee, Sang Min Lee, Chul Won Choi, Seok Jin Kim, Kihyun Kim, Je-Jung Lee, Korean Multiple Myeloma Working Party

ABSTRACT

This phase II study prospectively evaluated the efficacy and tolerability of an early change in induction therapy before autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients who failed to achieve more than a partial response (PR) after two cycles of a cyclophosphamide, thalidomide, and dexamethasone (CTD) regimen. Patients aged 18-65 years received two cycles of CTD therapy, and then the patients who achieved more than a PR received two additional cycles of CTD therapy, while those who failed to achieve more than a PR were given intensified therapy with four cycles of a Vel-CD regimen (bortezomib, cyclophosphamide, and dexamethasone). After completing primary chemotherapy, the patients underwent ASCT. This study initially enrolled 64 patients, although four were excluded. Of the patients, 60 were treated with CTD regimen and 8 patients also had the intensified Vel-CD regimen, of whom five showing improved responses. The overall response rate before ASCT in 59 patients was 94.9 %, including 27.1 % with a stringent complete response/complete response, 23.7 % with a very good partial response (VGPR), and 44.1 % with a PR. The median time to progression (TTP) was 33.2 months (95 % CI, 26.6-34.8). Patients who attained a VGPR or better after ASCT tended to have a longer TTP than the patients who did not (not reached vs. 24.2 months, P = 0.04). In conclusion, early response-adapted intensification with a Vel-CD regimen was a well-tolerated, effective strategy for improving the response before ASCT in patients with newly diagnosed MM. More... »

PAGES

1571-1577

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-014-2067-3

DOI

http://dx.doi.org/10.1007/s00277-014-2067-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041284205

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24728664


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Boronic Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bortezomib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dexamethasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Induction Chemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thalidomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Chonnam National University Hwasun Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411602.0", 
          "name": [
            "Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, 519-763, Hwasun, Jeollanamdo, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahn", 
        "givenName": "Seo-Yeon", 
        "id": "sg:person.0715206304.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715206304.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chonnam National University Hwasun Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411602.0", 
          "name": [
            "Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, 519-763, Hwasun, Jeollanamdo, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jung", 
        "givenName": "Sung-Hoon", 
        "id": "sg:person.01346642620.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346642620.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inje University Haeundae Paik Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411631.0", 
          "name": [
            "Inje University Haeundae Paik Hospital, Busan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joo", 
        "givenName": "Young Don", 
        "id": "sg:person.0730330375.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730330375.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inje University Busan Paik Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411625.5", 
          "name": [
            "Inje University Busan Paik Hospital, Busan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Won Sik", 
        "id": "sg:person.01031456242.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031456242.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inje University Busan Paik Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411625.5", 
          "name": [
            "Inje University Busan Paik Hospital, Busan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Sang Min", 
        "id": "sg:person.01315300754.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315300754.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Korea University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411134.2", 
          "name": [
            "Korea University Guro Hospital, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Choi", 
        "givenName": "Chul Won", 
        "id": "sg:person.0754502515.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754502515.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Seok Jin", 
        "id": "sg:person.01276437501.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276437501.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Kihyun", 
        "id": "sg:person.01135306324.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135306324.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chonnam National University Hwasun Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411602.0", 
          "name": [
            "Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, 519-763, Hwasun, Jeollanamdo, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Je-Jung", 
        "id": "sg:person.01204441075.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204441075.42"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Korean Multiple Myeloma Working Party", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/cncr.28325", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002413575"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2169/internalmedicine.52.9385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007179875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000339635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008076481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)61424-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008465800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.4250", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013176442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/clml.2010.n.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016766278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.1060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017061459"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.0100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018115379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.11644", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018639292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.1853", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020348325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-08-104984", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025328987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-10-116129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028530311"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2011.043372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030615705"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032025537", 
          "https://doi.org/10.1038/sj.bmt.1705307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.3087", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032541198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2006.09.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032631542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.27.9158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035435929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037240878", 
          "https://doi.org/10.1038/sj.bmt.1701062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037240878", 
          "https://doi.org/10.1038/sj.bmt.1701062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2005.05514.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038449835"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2005.05514.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038449835"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.17.9721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040936680"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-012-1237-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041643460", 
          "https://doi.org/10.1007/s12185-012-1237-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa022340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043734366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199607113350204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050074028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.11534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071145223"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-09", 
    "datePublishedReg": "2014-09-01", 
    "description": "This phase II study prospectively evaluated the efficacy and tolerability of an early change in induction therapy before autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients who failed to achieve more than a partial response (PR) after two cycles of a cyclophosphamide, thalidomide, and dexamethasone (CTD) regimen. Patients aged 18-65\u00a0years received two cycles of CTD therapy, and then the patients who achieved more than a PR received two additional cycles of CTD therapy, while those who failed to achieve more than a PR were given intensified therapy with four cycles of a Vel-CD regimen (bortezomib, cyclophosphamide, and dexamethasone). After completing primary chemotherapy, the patients underwent ASCT. This study initially enrolled 64 patients, although four were excluded. Of the patients, 60 were treated with CTD regimen and 8 patients also had the intensified Vel-CD regimen, of whom five showing improved responses. The overall response rate before ASCT in 59 patients was 94.9\u00a0%, including 27.1\u00a0% with a stringent complete response/complete response, 23.7\u00a0% with a very good partial response (VGPR), and 44.1\u00a0% with a PR. The median time to progression (TTP) was 33.2\u00a0months (95\u00a0% CI, 26.6-34.8). Patients who attained a VGPR or better after ASCT tended to have a longer TTP than the patients who did not (not reached vs. 24.2\u00a0months, P\u2009=\u20090.04). In conclusion, early response-adapted intensification with a Vel-CD regimen was a well-tolerated, effective strategy for improving the response before ASCT in patients with newly diagnosed MM. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00277-014-2067-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "93"
      }
    ], 
    "name": "Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study", 
    "pagination": "1571-1577", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c4aa568e067881cae7bcd05ac3a64a5e75fc45349e0c687f97646a80df708acf"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24728664"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-014-2067-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041284205"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-014-2067-3", 
      "https://app.dimensions.ai/details/publication/pub.1041284205"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00277-014-2067-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2067-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2067-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2067-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2067-3'


 

This table displays all metadata directly associated to this object as RDF triples.

301 TRIPLES      21 PREDICATES      74 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-014-2067-3 schema:about N33a33bf5db144b0f84c866d1780568a8
2 N3c8dad4cc1124b03864a57c8683638a1
3 N4a73e9e8c72b4ec8b1d5dc404656575d
4 N55c2f2c718d0415bb5490dee58f9c316
5 N683eb505d795416e8637771ceed35b78
6 N711ac3595a4e496db0066cfad1be07c3
7 N737072990f0a4c8eab7dfc83042cd5ad
8 N791f104fbee141d8b58f7ff0d62953c1
9 N8c9b72d951b44d28b842e49bc81440dc
10 N8cf4c9c974be4c97873dea5f5285777b
11 N9a2674b9fa394ddd9ff619584b316389
12 N9c92a5e4365d4f40b54b5a2387cb39eb
13 N9d0a8c4949124b6f879ddc7f9d648fdd
14 Nbd28bc216313463c94ba5d9e4a29755b
15 Nc8562d9714244b7b983a3d3e7521a25e
16 Nce93241af8e741eda1cfd166219890b8
17 Nd497f6df66704c728d580978e70fc918
18 Nd924be4a51054ae593aa363fcd682746
19 Nf132fb7f2af84d2a9f76eccd57c5d99e
20 Nf83cf6e343c04a328b8ed9e8d4865f0f
21 Nf99f3614a2934204b1c210d0ca8c92d5
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N91a581aa88fc4b04b7d545d36aa693ff
25 schema:citation sg:pub.10.1007/s12185-012-1237-0
26 sg:pub.10.1038/sj.bmt.1701062
27 sg:pub.10.1038/sj.bmt.1705307
28 https://doi.org/10.1002/cncr.28325
29 https://doi.org/10.1016/j.bbmt.2006.09.010
30 https://doi.org/10.1016/s0140-6736(10)61424-9
31 https://doi.org/10.1056/nejm199607113350204
32 https://doi.org/10.1056/nejmoa022340
33 https://doi.org/10.1111/j.1365-2141.2005.05514.x
34 https://doi.org/10.1159/000339635
35 https://doi.org/10.1182/blood-2007-08-104984
36 https://doi.org/10.1182/blood-2007-10-116129
37 https://doi.org/10.1200/jco.2006.09.0100
38 https://doi.org/10.1200/jco.2007.14.1853
39 https://doi.org/10.1200/jco.2008.17.9721
40 https://doi.org/10.1200/jco.2008.18.3087
41 https://doi.org/10.1200/jco.2008.21.1060
42 https://doi.org/10.1200/jco.2009.25.4250
43 https://doi.org/10.1200/jco.2009.27.9158
44 https://doi.org/10.2169/internalmedicine.52.9385
45 https://doi.org/10.3324/haematol.11534
46 https://doi.org/10.3324/haematol.11644
47 https://doi.org/10.3324/haematol.2011.043372
48 https://doi.org/10.3816/clml.2010.n.007
49 schema:datePublished 2014-09
50 schema:datePublishedReg 2014-09-01
51 schema:description This phase II study prospectively evaluated the efficacy and tolerability of an early change in induction therapy before autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients who failed to achieve more than a partial response (PR) after two cycles of a cyclophosphamide, thalidomide, and dexamethasone (CTD) regimen. Patients aged 18-65 years received two cycles of CTD therapy, and then the patients who achieved more than a PR received two additional cycles of CTD therapy, while those who failed to achieve more than a PR were given intensified therapy with four cycles of a Vel-CD regimen (bortezomib, cyclophosphamide, and dexamethasone). After completing primary chemotherapy, the patients underwent ASCT. This study initially enrolled 64 patients, although four were excluded. Of the patients, 60 were treated with CTD regimen and 8 patients also had the intensified Vel-CD regimen, of whom five showing improved responses. The overall response rate before ASCT in 59 patients was 94.9 %, including 27.1 % with a stringent complete response/complete response, 23.7 % with a very good partial response (VGPR), and 44.1 % with a PR. The median time to progression (TTP) was 33.2 months (95 % CI, 26.6-34.8). Patients who attained a VGPR or better after ASCT tended to have a longer TTP than the patients who did not (not reached vs. 24.2 months, P = 0.04). In conclusion, early response-adapted intensification with a Vel-CD regimen was a well-tolerated, effective strategy for improving the response before ASCT in patients with newly diagnosed MM.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree false
55 schema:isPartOf N859e3e6513c348d6ba24ae75058f11f3
56 N936621f1c7df48b88f30f772dd80bbe3
57 sg:journal.1018247
58 schema:name Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study
59 schema:pagination 1571-1577
60 schema:productId N0304aad7ef184f21973606c5096b758f
61 N134d6c260ad04ca0b8f857db80a62945
62 N49256745768148238a929ce14b496c1c
63 Na49394fbe17145fba1c307d7047a99be
64 Nd7afbb606b0b4c159d3e7332992a51e9
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041284205
66 https://doi.org/10.1007/s00277-014-2067-3
67 schema:sdDatePublished 2019-04-10T21:32
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N7a6ff4686f104d2684115645c2cff958
70 schema:url http://link.springer.com/10.1007/s00277-014-2067-3
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N0197534f38724e779876063b2cfc762b schema:name Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea
75 rdf:type schema:Organization
76 N0304aad7ef184f21973606c5096b758f schema:name nlm_unique_id
77 schema:value 9107334
78 rdf:type schema:PropertyValue
79 N134d6c260ad04ca0b8f857db80a62945 schema:name doi
80 schema:value 10.1007/s00277-014-2067-3
81 rdf:type schema:PropertyValue
82 N33a33bf5db144b0f84c866d1780568a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Adult
84 rdf:type schema:DefinedTerm
85 N378c262338e149cf8349632e71325691 schema:name Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea
86 rdf:type schema:Organization
87 N3c8dad4cc1124b03864a57c8683638a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Multiple Myeloma
89 rdf:type schema:DefinedTerm
90 N49256745768148238a929ce14b496c1c schema:name pubmed_id
91 schema:value 24728664
92 rdf:type schema:PropertyValue
93 N4a73e9e8c72b4ec8b1d5dc404656575d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Young Adult
95 rdf:type schema:DefinedTerm
96 N55c2f2c718d0415bb5490dee58f9c316 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Boronic Acids
98 rdf:type schema:DefinedTerm
99 N5738c0a262524f6488548fb281edf2dc rdf:first sg:person.01204441075.42
100 rdf:rest Nb423ee31f31f4502901f60253b46fcc9
101 N683eb505d795416e8637771ceed35b78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Middle Aged
103 rdf:type schema:DefinedTerm
104 N711ac3595a4e496db0066cfad1be07c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Remission Induction
106 rdf:type schema:DefinedTerm
107 N737072990f0a4c8eab7dfc83042cd5ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N74e55969ae3e4dae811ae3504094bb15 rdf:first sg:person.0730330375.72
111 rdf:rest Naaa583d2fb2b402582c73295d190be3e
112 N791f104fbee141d8b58f7ff0d62953c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Patient Selection
114 rdf:type schema:DefinedTerm
115 N7a6ff4686f104d2684115645c2cff958 schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 N7fd3c5b1f5d6463cae0c26fc773301ad rdf:first sg:person.0754502515.81
118 rdf:rest Nc21237fa9f9a4e75a0e079209630eb58
119 N859e3e6513c348d6ba24ae75058f11f3 schema:volumeNumber 93
120 rdf:type schema:PublicationVolume
121 N8c9b72d951b44d28b842e49bc81440dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Dexamethasone
123 rdf:type schema:DefinedTerm
124 N8cf4c9c974be4c97873dea5f5285777b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Cyclophosphamide
126 rdf:type schema:DefinedTerm
127 N91a581aa88fc4b04b7d545d36aa693ff rdf:first sg:person.0715206304.07
128 rdf:rest Nf105088c1ec3472fa3f021317239090c
129 N936621f1c7df48b88f30f772dd80bbe3 schema:issueNumber 9
130 rdf:type schema:PublicationIssue
131 N9a2674b9fa394ddd9ff619584b316389 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Pyrazines
133 rdf:type schema:DefinedTerm
134 N9c92a5e4365d4f40b54b5a2387cb39eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Antineoplastic Combined Chemotherapy Protocols
136 rdf:type schema:DefinedTerm
137 N9d0a8c4949124b6f879ddc7f9d648fdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Combined Modality Therapy
139 rdf:type schema:DefinedTerm
140 Na34e63bdaaa143009d5dfbe5e8b91678 rdf:first sg:person.01135306324.87
141 rdf:rest N5738c0a262524f6488548fb281edf2dc
142 Na49394fbe17145fba1c307d7047a99be schema:name dimensions_id
143 schema:value pub.1041284205
144 rdf:type schema:PropertyValue
145 Naaa583d2fb2b402582c73295d190be3e rdf:first sg:person.01031456242.28
146 rdf:rest Nec1645a7b16b4384923bf8a53328a279
147 Nb423ee31f31f4502901f60253b46fcc9 rdf:first Neb2ec0c6cb0744b0a6d1a6049aea8a06
148 rdf:rest rdf:nil
149 Nbd28bc216313463c94ba5d9e4a29755b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Aged
151 rdf:type schema:DefinedTerm
152 Nc21237fa9f9a4e75a0e079209630eb58 rdf:first sg:person.01276437501.28
153 rdf:rest Na34e63bdaaa143009d5dfbe5e8b91678
154 Nc8562d9714244b7b983a3d3e7521a25e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Transplantation, Autologous
156 rdf:type schema:DefinedTerm
157 Nce93241af8e741eda1cfd166219890b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Induction Chemotherapy
159 rdf:type schema:DefinedTerm
160 Nd497f6df66704c728d580978e70fc918 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Thalidomide
162 rdf:type schema:DefinedTerm
163 Nd7afbb606b0b4c159d3e7332992a51e9 schema:name readcube_id
164 schema:value c4aa568e067881cae7bcd05ac3a64a5e75fc45349e0c687f97646a80df708acf
165 rdf:type schema:PropertyValue
166 Nd924be4a51054ae593aa363fcd682746 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Adolescent
168 rdf:type schema:DefinedTerm
169 Neb2ec0c6cb0744b0a6d1a6049aea8a06 schema:familyName Korean Multiple Myeloma Working Party
170 rdf:type schema:Person
171 Nec1645a7b16b4384923bf8a53328a279 rdf:first sg:person.01315300754.59
172 rdf:rest N7fd3c5b1f5d6463cae0c26fc773301ad
173 Nf105088c1ec3472fa3f021317239090c rdf:first sg:person.01346642620.39
174 rdf:rest N74e55969ae3e4dae811ae3504094bb15
175 Nf132fb7f2af84d2a9f76eccd57c5d99e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Bortezomib
177 rdf:type schema:DefinedTerm
178 Nf83cf6e343c04a328b8ed9e8d4865f0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Neoadjuvant Therapy
180 rdf:type schema:DefinedTerm
181 Nf99f3614a2934204b1c210d0ca8c92d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Hematopoietic Stem Cell Transplantation
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
188 schema:name Oncology and Carcinogenesis
189 rdf:type schema:DefinedTerm
190 sg:journal.1018247 schema:issn 1269-3286
191 1279-8509
192 schema:name Annals of Hematology
193 rdf:type schema:Periodical
194 sg:person.01031456242.28 schema:affiliation https://www.grid.ac/institutes/grid.411625.5
195 schema:familyName Lee
196 schema:givenName Won Sik
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031456242.28
198 rdf:type schema:Person
199 sg:person.01135306324.87 schema:affiliation N0197534f38724e779876063b2cfc762b
200 schema:familyName Kim
201 schema:givenName Kihyun
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135306324.87
203 rdf:type schema:Person
204 sg:person.01204441075.42 schema:affiliation https://www.grid.ac/institutes/grid.411602.0
205 schema:familyName Lee
206 schema:givenName Je-Jung
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204441075.42
208 rdf:type schema:Person
209 sg:person.01276437501.28 schema:affiliation N378c262338e149cf8349632e71325691
210 schema:familyName Kim
211 schema:givenName Seok Jin
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276437501.28
213 rdf:type schema:Person
214 sg:person.01315300754.59 schema:affiliation https://www.grid.ac/institutes/grid.411625.5
215 schema:familyName Lee
216 schema:givenName Sang Min
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315300754.59
218 rdf:type schema:Person
219 sg:person.01346642620.39 schema:affiliation https://www.grid.ac/institutes/grid.411602.0
220 schema:familyName Jung
221 schema:givenName Sung-Hoon
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346642620.39
223 rdf:type schema:Person
224 sg:person.0715206304.07 schema:affiliation https://www.grid.ac/institutes/grid.411602.0
225 schema:familyName Ahn
226 schema:givenName Seo-Yeon
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715206304.07
228 rdf:type schema:Person
229 sg:person.0730330375.72 schema:affiliation https://www.grid.ac/institutes/grid.411631.0
230 schema:familyName Joo
231 schema:givenName Young Don
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730330375.72
233 rdf:type schema:Person
234 sg:person.0754502515.81 schema:affiliation https://www.grid.ac/institutes/grid.411134.2
235 schema:familyName Choi
236 schema:givenName Chul Won
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754502515.81
238 rdf:type schema:Person
239 sg:pub.10.1007/s12185-012-1237-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041643460
240 https://doi.org/10.1007/s12185-012-1237-0
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/sj.bmt.1701062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037240878
243 https://doi.org/10.1038/sj.bmt.1701062
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/sj.bmt.1705307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032025537
246 https://doi.org/10.1038/sj.bmt.1705307
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1002/cncr.28325 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002413575
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/j.bbmt.2006.09.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032631542
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/s0140-6736(10)61424-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008465800
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejm199607113350204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050074028
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejmoa022340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043734366
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1111/j.1365-2141.2005.05514.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038449835
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1159/000339635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008076481
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1182/blood-2007-08-104984 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025328987
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1182/blood-2007-10-116129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028530311
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1200/jco.2006.09.0100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018115379
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1200/jco.2007.14.1853 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020348325
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1200/jco.2008.17.9721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040936680
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1200/jco.2008.18.3087 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032541198
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2008.21.1060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017061459
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2009.25.4250 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013176442
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2009.27.9158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035435929
279 rdf:type schema:CreativeWork
280 https://doi.org/10.2169/internalmedicine.52.9385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007179875
281 rdf:type schema:CreativeWork
282 https://doi.org/10.3324/haematol.11534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071145223
283 rdf:type schema:CreativeWork
284 https://doi.org/10.3324/haematol.11644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018639292
285 rdf:type schema:CreativeWork
286 https://doi.org/10.3324/haematol.2011.043372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030615705
287 rdf:type schema:CreativeWork
288 https://doi.org/10.3816/clml.2010.n.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016766278
289 rdf:type schema:CreativeWork
290 https://www.grid.ac/institutes/grid.411134.2 schema:alternateName Korea University Medical Center
291 schema:name Korea University Guro Hospital, Seoul, Republic of Korea
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.411602.0 schema:alternateName Chonnam National University Hwasun Hospital
294 schema:name Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, 519-763, Hwasun, Jeollanamdo, Republic of Korea
295 rdf:type schema:Organization
296 https://www.grid.ac/institutes/grid.411625.5 schema:alternateName Inje University Busan Paik Hospital
297 schema:name Inje University Busan Paik Hospital, Busan, Republic of Korea
298 rdf:type schema:Organization
299 https://www.grid.ac/institutes/grid.411631.0 schema:alternateName Inje University Haeundae Paik Hospital
300 schema:name Inje University Haeundae Paik Hospital, Busan, Republic of Korea
301 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...